Caris Operating Cycle from 2010 to 2026

CAI Stock  USD 26.50  0.49  1.88%   
Caris Life's Operating Cycle is increasing with slightly volatile movements from year to year. Operating Cycle is estimated to finish at 189.05 this year. For the period between 2010 and 2026, Caris Life, Operating Cycle quarterly trend regression had mean deviation of  19.67 and range of 85.2567. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
160.99
Current Value
189.05
Quarterly Volatility
24.87686772
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Caris Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caris Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 61.8 M, Interest Expense of 33.1 M or Total Revenue of 497.8 M, as well as many indicators such as Price To Sales Ratio of 16.34, Dividend Yield of 0.0333 or Days Sales Outstanding of 175. Caris financial statements analysis is a perfect complement when working with Caris Life Valuation or Volatility modules.
  
Build AI portfolio with Caris Stock
Check out the analysis of Caris Life Correlation against competitors.

Latest Caris Life's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Caris Life Sciences over the last few years. It is Caris Life's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caris Life's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Caris Operating Cycle Regression Statistics

Arithmetic Mean140.51
Geometric Mean138.43
Coefficient Of Variation17.70
Mean Deviation19.67
Median139.99
Standard Deviation24.88
Sample Variance618.86
Range85.2567
R-Value0.54
Mean Square Error468.10
R-Squared0.29
Significance0.03
Slope2.66
Total Sum of Squares9,902

Caris Operating Cycle History

2026 189.05
2025 160.99
2024 139.99
2023 148.42
2021 152.84
2020 179.14
2019 139.92

About Caris Life Financial Statements

Investors use fundamental indicators, such as Caris Life's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Caris Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Operating Cycle 160.99  189.05 

Currently Active Assets on Macroaxis

When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:
Check out the analysis of Caris Life Correlation against competitors.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is there potential for Trading Companies & Distributors market expansion? Will Caris introduce new products? Factors like these will boost the valuation of Caris Life. Projected growth potential of Caris fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.25)
Revenue Per Share
3.18
Quarterly Revenue Growth
0.499
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Caris Life's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Caris Life should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Caris Life's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.